Fig. 9From: Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivoSerum level of cytokine a interleukin-12, b interleukin-2, and c interferon-γ from normal and colon cancer-challenged mice (negative control, AF2240-i, and rAF-IL12) after 28-days of treatment. Data are presented as mean ± S.E.M. of six mice per group. Mean values with statistical difference at p ≤ 0.05 between groups are indicated with *Back to article page